ClinicalTrials.Veeva

Menu
H

Hospital Sibu | Clinical Research Centre

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AK0529
Apixaban
Semaglutide
Rilematovir
Seltorexant
JNJ-64179375
Pimodivir
Sisunatovir
RO7434656
JNJ-53718678

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 18 total trials

A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression (IMAGINATION)

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of RO7434656, a novel Antisense Oligonucleotide (ASO) therapy in...

Enrolling
Primary IgA Nephropathy
Drug: RO7434656
Drug: Placebo
Locations recently updated

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardiovascular...

Enrolling
Cardiovascular Disease
Drug: Semaglutide
Drug: Cagrilintide

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Baxalta logo
K
L
Novo Nordisk logo
Pfizer logo
Regeneron Pharmaceuticals logo
Roche logo
Sandoz logo
Seqirus logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems